Kukje Pharma Co., Ltd. (KRX:002720)
South Korea
· Delayed Price · Currency is KRW 4,365.00
+45.00 (1.04%)
At close: Dec 5, 2025
Kukje Pharma Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 88,882 | 103,034 | 119,890 | 106,115 | 112,861 | 176,865 | Upgrade
|
| Market Cap Growth | -22.47% | -14.06% | 12.98% | -5.98% | -36.19% | 118.14% | Upgrade
|
| Enterprise Value | 101,247 | 124,008 | 140,751 | 127,215 | 143,804 | 207,752 | Upgrade
|
| Last Close Price | 4365.00 | 5028.70 | 5883.38 | 5205.69 | 5534.71 | 8670.79 | Upgrade
|
| PE Ratio | 12.45 | 19.80 | - | 29.83 | - | 80.28 | Upgrade
|
| PS Ratio | 0.51 | 0.66 | 0.89 | 0.84 | 0.94 | 1.36 | Upgrade
|
| PB Ratio | 0.93 | 1.15 | 1.41 | 1.43 | 1.65 | 2.51 | Upgrade
|
| P/TBV Ratio | 0.95 | 1.16 | 1.43 | 1.45 | 1.67 | 2.54 | Upgrade
|
| P/FCF Ratio | 9.43 | 100.14 | 47.40 | 20.23 | 14.65 | - | Upgrade
|
| P/OCF Ratio | 8.12 | 26.15 | 33.53 | 16.32 | 11.76 | 34.68 | Upgrade
|
| EV/Sales Ratio | 0.58 | 0.79 | 1.04 | 1.00 | 1.20 | 1.59 | Upgrade
|
| EV/EBITDA Ratio | 8.53 | 12.52 | 63.55 | 13.03 | 52.42 | 21.49 | Upgrade
|
| EV/EBIT Ratio | 11.68 | 18.50 | - | 24.13 | - | 34.39 | Upgrade
|
| EV/FCF Ratio | 10.74 | 120.53 | 55.65 | 24.26 | 18.66 | - | Upgrade
|
| Debt / Equity Ratio | 0.32 | 0.33 | 0.36 | 0.39 | 0.53 | 0.54 | Upgrade
|
| Debt / EBITDA Ratio | 2.57 | 2.98 | 13.84 | 2.93 | 13.12 | 3.94 | Upgrade
|
| Debt / FCF Ratio | 3.23 | 28.68 | 12.12 | 5.45 | 4.67 | - | Upgrade
|
| Asset Turnover | 1.01 | 0.95 | 0.90 | 0.92 | 0.84 | 0.93 | Upgrade
|
| Inventory Turnover | 3.42 | 3.39 | 3.14 | 3.27 | 3.42 | 3.43 | Upgrade
|
| Quick Ratio | 0.74 | 1.13 | 0.53 | 0.54 | 0.58 | 0.51 | Upgrade
|
| Current Ratio | 1.19 | 2.00 | 0.92 | 1.01 | 0.88 | 0.90 | Upgrade
|
| Return on Equity (ROE) | 7.71% | 5.97% | -10.58% | 4.97% | -2.24% | 3.34% | Upgrade
|
| Return on Assets (ROA) | 3.16% | 2.55% | -0.83% | 2.38% | -0.73% | 2.70% | Upgrade
|
| Return on Capital (ROIC) | 4.42% | 3.57% | -1.14% | 3.18% | -0.98% | 3.68% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.30% | 4.90% | -1.90% | 5.90% | -2.00% | 6.70% | Upgrade
|
| Earnings Yield | 8.03% | 5.05% | -7.02% | 3.35% | -1.38% | 1.25% | Upgrade
|
| FCF Yield | 10.60% | 1.00% | 2.11% | 4.94% | 6.83% | -3.67% | Upgrade
|
| Dividend Yield | 0.69% | 0.60% | - | - | - | - | Upgrade
|
| Payout Ratio | 8.56% | - | - | - | - | - | Upgrade
|
| Buyback Yield / Dilution | -0.16% | -0.53% | 0.03% | 0.03% | 0.03% | 0.00% | Upgrade
|
| Total Shareholder Return | 0.54% | 0.07% | 0.03% | 0.03% | 0.03% | 0.00% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.